Citation Impact
Citing Papers
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
2015 Standout
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
The relationship between subtypes of depression and cardiovascular disease: a systematic review of biological models
2012
Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways
2012
Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples
2010
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
Oligodendrocyte ablation triggers central pain independently of innate or adaptive immune responses in mice
2014
Adipose tissue, adipokines, and inflammation
2005 Standout
Sleep Disturbance, Sleep Duration, and Inflammation: A Systematic Review and Meta-Analysis of Cohort Studies and Experimental Sleep Deprivation
2015 Standout
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
2006 Standout
POLY(ADP-RIBOSE) SYNTHETASE INHIBITION PREVENTS LIPOPOLYSACCHARIDE-INDUCED PEROXYNITRITE MEDIATED DAMAGE IN DIAPHRAGM
2002
Non-alcoholic fatty liver disease – A global public health perspective
2018 Standout
Mechanisms of hypoxia signalling: new implications for nephrology
2019 StandoutNobel
Oxidative stress and steatosis are cofactors of liver injury in primary biliary cirrhosis
2010
The Evolving Role of Leptin and Adiponectin in Chronic Liver Diseases
2006
Mechanisms of liver fibrosis
2005
N‐acetylcysteine modulates doxorubicin‐induced oxidative stress and antioxidant vitamin concentrations in liver of rats
2010
Chronic inflammation in the etiology of disease across the life span
2019 Standout
IDO chronic immune activation and tryptophan metabolic pathway: A potential pathophysiological link between depression and obesity
2017
Advances in metal-induced oxidative stress and human disease
2011 Standout
Inflammation in End-Stage Renal Disease-What Have We Learned in 10 Years?
2010
Endocan: A novel inflammatory indicator in cardiovascular disease?
2015 Standout
PI-3 K/AKT and ERK signaling pathways mediate leptin-induced inhibition of PPARγ gene expression in primary rat hepatic stellate cells
2009
The metabolic syndrome
2010 Standout
The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease
2008
The weight of leptin in immunity
2004
Reactive oxygen species: from health to disease
2012 Standout
Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis
2010 Standout
Hepatic steatosis in obese patients: clinical aspects and prognostic significance
2004
Chronic Low-Grade Inflammation in Elderly Persons Is Associated with Altered Tryptophan and Tyrosine Metabolism: Role in Neuropsychiatric Symptoms
2011
Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression
2010
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
2017 Standout
A review of peripheral biomarkers in major depression: The potential of inflammatory and oxidative stress biomarkers
2013
Chronic kidney disease alters intestinal microbial flora
2012 Standout
The Association of Fatty Liver and Diabetes Risk.
2003
Mitochondrial dysfunction in NASH: Causes, consequences and possible means to prevent it
2006
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical Implications
2009 Standout
Human nutrition, the gut microbiome and the immune system
2011 StandoutNature
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
2016 Standout
Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis
2013
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
The metabolic syndrome
2005 Standout
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
Obesity in autoimmune diseases: Not a passive bystander
2014
Non-Alcoholic Fatty Liver Disease in Young Adult Severely Obese Non-Diabetic Patients in South Italy
2005
Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat?
2005
Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults
2011 Standout
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis
2015
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
2003 Standout
Long‐term follow‐up of patients with NAFLD and elevated liver enzymes†‡
2006 Standout
Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States
2003
The suffocating kidney: tubulointerstitial hypoxia in end-stage renal disease
2010
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
2012 Standout
Oxidant Stress and Antioxidant Status Among Patients With Nonalcoholic Fatty Liver Disease (NAFLD)
2006
The effects of air pollution on adverse birth outcomes
2014 Standout
Activation of apoptosis signalling pathways by reactive oxygen species
2016 Standout
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease
2018
The role of adipokines in liver fibrosis
2008
Magnesium in CKD: more than a calcification inhibitor?
2014
SAFETY Study: Alanine Aminotransferase Cutoff Values Are Set Too High for Reliable Detection of Pediatric Chronic Liver Disease
2010
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
2012 Standout
Metformin in the treatment of patients with non‐alcoholic steatohepatitis
2004
Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease
2018 Standout
Serum Magnesium and Mortality in Hemodialysis Patients in the United States: A Cohort Study
2015
Asymmetric Dimethylarginine: A Cardiovascular Risk Factor and a Uremic Toxin Coming of Age?
2005
Nonalcoholic Fatty Liver Disease as a Contributor to Hypercoagulation and Thrombophilia in the Metabolic Syndrome
2009
Molecular Mechanisms of Lipotoxicity in Nonalcoholic Fatty Liver Disease
2008
NAFLD: A multisystem disease
2015 Standout
Adipokines in liver diseases #
2009
Chronic Kidney Disease
2016 Standout
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Adipocytokines: mediators linking adipose tissue, inflammation and immunity
2006 Standout
Adipose Tissue as an Endocrine Organ
2004 Standout
Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters
2009 Standout
Hypomagnesemia and the Risk of Death and GFR Decline in Chronic Kidney Disease
2013
3-Nitrotyrosine in Atherosclerotic Blood Vessels
2003
Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease
2011 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Approach to the Pathogenesis and Treatment of Nonalcoholic Steatohepatitis
2004
Pain regulation by non-neuronal cells and inflammation
2016 StandoutScience
Non-alcoholic and alcoholic Fatty Liver Disease - two Diseases of Affluence associated with the Metabolic Syndrome and Type 2 Diabetes: the FIN-D2D Survey
2010
Hepatic Steatosis, Insulin Resistance, and Adipose Tissue Disorders
2002
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Adipokines in Nonalcoholic Steatohepatitis: From Pathogenesis to Implications in Diagnosis and Therapy
2009
Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up
2014 Standout
Evaluation of blood oxidative stress‐related parameters in alcoholic liver disease and non‐alcoholic fatty liver disease
2008
Fatty Liver
2007
Nebivolol
2006
Estimating Glomerular Filtration Rate in Older People
2014
The Role of Oxidative Stress and Antioxidants in Liver Diseases
2015 Standout
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
Nebivolol
2009
Leptin and Cardiovascular Disease
2008
Hepatic Steatosis, Insulin Resistance, and Adipose Tissue Disorders
2002
Works of Halıl Yaman being referenced
Endogenous Testosterone, Endothelial Dysfunction, and Cardiovascular Events in Men with Nondialysis Chronic Kidney Disease
2011
Serum haptoglobin levels in patients with melancholic and nonmelancholic major depression
2011
Effects of N-Acetylcysteine, Deferoxamine and Selenium on Doxorubicin-Induced Hepatotoxicity
2009
Serum Leptin Levels in Patients With Nonalcoholic Steatohepatitis
2000
The effect of hypothyroidism, hyperthyroidism, and their treatment on parameters of oxidative stress and antioxidant status
2008
Relationship between Serum Magnesium Levels and Cardiovascular Events in Chronic Kidney Disease Patients
2012
Soluble TWEAK Plasma Levels as a Novel Biomarker of Endothelial Function in Patients with Chronic Kidney Disease
2009
Hyperbaric Oxygen Treatment Augments the Efficacy of a Losartan Regime in an Experimental Nephrotic Syndrome Model
2006
Comparison of aromatase inhibitor (letrozole) and immunomodulators (infliximab and etanercept) on the regression of endometriotic implants in a rat model
2010
Systemic Markers of Lipid Peroxidation and Antioxidants in Patients with Nonalcoholic Fatty Liver Disease
2005
FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease
2010
The Comparative Effects of Valsartan and Amlodipine on Vascular Microinflammation in Newly Diagnosed Hypertensive Patients
2012
Leptin levels in the acute stage of ulcerative colitis
2004
The association between serum levels of neopterin and number of depressive episodes of major depression
2010
The Effect of Escherichia Coli-Derived Lipopolysaccharides on Plasma Levels of Malondialdehyde and 3-Nitrotyrosine
2001
The protective effects of ozone therapy in a rat model of acetaminophen-induced liver injury
2012
Combined Therapy with Renin-Angiotensin System and Calcium Channel Blockers in Type 2 Diabetic Hypertensive Patients with Proteinuria
2010
Comparative effects of nebivolol and metoprolol on oxidative stress, insulin resistance, plasma adiponectin and soluble P-selectin levels in hypertensive patients
2006
Elevated Plasma Concentration of Asymmetric Dimethylarginine That Is Reduced by Single Dose Testosterone Administration in Idiopathic Hypogonadotropic Hypogonadism Patients
2005